Connect your AI

Savara SVRA Change in Other Assets

Change in Other Assets at other companies

Innoviva, Inc.INVA

$8.37M+1,618%

Theravance BiopharmaTBPH

-$1.03M-211%

Eton Pharmaceuticals, Inc.ETON

-$1.75M+41.0%

TRV

Trevi Therapeutics, Inc.TRVI

$2.84M+369%

Viridian Therapeutics, Inc.VRDN

$2.33M+919%

PVL

Palvella TherapeuticsPVLA

$357K+144%

Other financials

Income statement

Revenue-—

Operating income-$39.0M-37.1%

Net income-$37.3M-40.0%

EPS (diluted)-$0.15-25.0%

Balance sheet

Cash & equivalents$38.8M+98.4%

Total debt$30.1M+1.8%

Total equity$176.0M+19.1%

Total assets$221.6M+17.1%

Cash flow

Operating cash flow-$33.0M-21.5%

CapEx$54.0K+1,700%

Free cash flow-$33.1M-21.7%

Valuation

Market cap$1.19B+134%

Enterprise value$1.19B+127%

P/S4,648.7×—

Profitability

Operating margin-19,183.3%—

Net margin-19,305.1%—

FCF margin-15,518.7%—

Returns & leverage

Return on equity-80%+4.7pp

Debt / equity0.2×0.0×

Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Savara's change in other assets?: Savara (SVRA) reported change in other assets of $639K in Q1 2026.
How has Savara's change in other assets changed year-over-year?: Savara's change in other assets increased by 174.4% year-over-year, from -$859K to $639K.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.